The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women: An analysis of the tradeoffs
- 31 August 1995
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 99 (2) , 180-189
- https://doi.org/10.1016/s0002-9343(99)80138-7
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The case for clinical trials of tamoxifen for prevention of breast cancerThe Lancet, 1992
- Tamoxifen: disease prevention or disease substitution?The Lancet, 1992
- Breast CancerNew England Journal of Medicine, 1992
- Tamoxifen QuandaryScience News, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- Screening for Breast CancerAnnals of Internal Medicine, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- The Markov Process in Medical PrognosisMedical Decision Making, 1983